Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Salvatore Brugaletta

October 31, 2016

REGISTER for free or LOG IN to view this content

Trial #2 - The Essentials of ... the MATRIX Trial – Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Coronary

Presentation

TCT 2016

ACS/AMI

Up Next

Presentation TCT 2016

What Have We Learned From Contemporary Left Main Observational Studies IV? FLORENCE-LM Registry

Presenter: David Antoniucci (RETIRED)

October 31, 2016

More slides +

Presentation TCT 2016

DEBATE: Predicting Thrombotic Events in Patients With STEMI and Multivessel Disease: The Degree of Stenosis/Ischemia Is Most Important!

Presenter: Anthony H. Gershlick

October 31, 2016

Presentation TCT 2016

Failure Modes of Bioresorbable Scaffolds: From the Obvious (Strut Thickness Considerations) to the Novel (Intraluminal Scaffold Dismantling)

Presenter: Juan F. Granada

October 31, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.